What is Ganga Pharmaceuticals share price return in the past 10 years?

Data is not available for this company

What is the P/E ratio of Ganga Pharmaceuticals?

The latest standalone P/E ratio of Ganga Pharmaceuticals as of 05-Apr-2024 is 289.13.

What is the P/B ratio of Ganga Pharmaceuticals?

The latest standalone P/B ratio of Ganga Pharmaceuticals as of 05-Apr-2024 is 1.74.

What is the 52-week high and low of Ganga Pharmaceuticals?

The 52-week high of Ganga Pharmaceuticals is Rs. 28.49 and the 52-week low is Rs. 7.50.

Ganga Pharmaceuticals Ltd - Stock Valuation and Financial Performance

Name: Ganga Pharmaceuticals
Brand: Ganga Pharmaceuticals

BSE: 539680 | NSE: | Pharmaceuticals & Drugs | Small Cap

Place order

Ganga Pharma. Share Price

₹23.50 0.00 0.00%
as on 05-Apr'24 16:01

DeciZen - make an informed investing decision on Ganga Pharma.

Based on:

Data

M-Cap below 100cr DeciZen not available

Ganga Pharmaceuticals stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

289.13

Market Cap:

11.4 Cr.

52-wk low:

7.5

52-wk high:

28.5

Is Ganga Pharmaceuticals Ltd an attractive stock to invest in?

1. Is Ganga Pharmaceuticals Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Ganga Pharmaceuticals Ltd is a below average quality company.

2. Is Ganga Pharmaceuticals Ltd undervalued or overvalued?

The key valuation ratios of Ganga Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Ganga Pharmaceuticals Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Ganga Pharmaceuticals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Ganga Pharma.:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
ROCE % ⓘ	5.4%	5.6%	4.7%	4.2%	4.2%	5.2%	5.2%	2.3%	2.4%	2.4%	-
Value Creation Index ⓘ	-0.6	-0.6	-0.7	-0.7	-0.7	-0.6	-0.6	-0.8	-0.8	-0.8	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	2.6	2.6	2.6	3	3.1	3.4	3.1	2.4	2.5	2.6	3
Sales YoY Gr.	-	1.6%	0.8%	14.5%	1.3%	10.2%	-8.3%	-23.1%	5.1%	4%	-
Adj EPS ⓘ	0.1	0.1	0.1	0.2	0.2	0.5	0.5	0.1	0.1	0.1	0.1
YoY Gr.	-	8.3%	-7.7%	50%	27.8%	100%	0%	-89.1%	80%	11.1%	-
BVPS (₹) ⓘ	10.2	10.3	11.2	12	12.2	12.7	13.2	13.2	13.3	13.4	13.5
Adj Net Profit ⓘ	0	0	0.1	0.1	0.1	0.2	0.2	0	0	0	0
Cash Flow from Ops. ⓘ	-0.2	0.3	-1.1	0.1	0.2	0.1	-0.3	-0.2	-0.2	0	-
Debt/CF from Ops. ⓘ	-9.8	8	-2.1	46.7	8.6	16.5	-4.8	-9.8	-9.2	-45.8	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	0.1%	-3.2%	-5.6%	4%
Adj EPS ⓘ	-2%	-15.3%	-39.9%	11.1%
BVPSⓘ	3.1%	1.9%	0.6%	0.8%
Share Price	-	31.4%	46.3%	68.7%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
Return on Equity % ⓘ	1.2	1.3	1.3	1.5	1.9	3.7	3.6	0.4	0.7	0.7	0.6
Op. Profit Mgn % ⓘ	8.8	7.9	11.5	10.2	10.5	12.5	12.6	1.4	1.7	0.2	-0.1
Net Profit Mgn % ⓘ	1.2	1.3	1.9	2.5	3.1	5.6	6.1	0.9	1.5	1.5	1.5
Debt to Equity ⓘ	0.8	0.8	0.5	0.4	0.4	0.4	0.3	0.3	0.4	0.3	0.2
Working Cap Days ⓘ	559	591	689	737	810	746	791	1,041	1,030	1,019	237
Cash Conv. Cycle ⓘ	163	165	200	244	220	143	167	230	210	198	146

Recent Performance Summary

Sales growth is good in last 4 quarters at 10.27%

Return on Equity has declined versus last 3 years average to 0.60%

Sales growth has been subdued in last 3 years -5.61%

Net Profit has been subdued in last 3 years -39.87%

Latest Financials - Ganga Pharmaceuticals Ltd.

	Standalone	Consolidated
TTM EPS (₹)	0.1	-
TTM Sales (₹ Cr.)	2.6	-
BVPS (₹.) ⓘ	13.5	-
Reserves (₹ Cr.) ⓘ	2	-
P/BV ⓘ	1.74	-
PE ⓘ	289.13	-

From the Market
52 Week Low / High (₹)	7.50 / 28.49
All Time Low / High (₹)	5.00 / 28.49
Market Cap (₹ Cr.)	11.4
Equity (₹ Cr.)	4.8
Face Value (₹)	10
Industry PE ⓘ	47.8

Management X-Ray of Ganga Pharma.:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Ganga Pharma.

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Ganga Pharma.

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Sales	2.57	2.61	2.63	3.01	3.05	3.36	3.08	2.37	2.49	2.59
Operating Expenses ⓘ	2.35	2.40	2.33	2.70	2.73	2.94	2.69	2.34	2.45	2.58
Manufacturing Costs	0.42	0.27	0.50	0.10	0.14	0.18	0.05	0.02	-0.01	-0.06
Material Costs	0.92	1.07	0.56	0.80	0.86	0.93	1.23	1.21	1.29	1.30
Employee Cost	0	0.05	0.06	0.16	0.18	0.32	0.05	0.03	0.04	0.04
Other Costs ⓘ	1	1.01	1.21	1.63	1.55	1.51	1.37	1.07	1.13	1.30
Operating Profit ⓘ	0.23	0.21	0.30	0.31	0.32	0.42	0.39	0.03	0.04	0
Operating Profit Margin (%)	8.8%	7.9%	11.5%	10.2%	10.5%	12.5%	12.6%	1.4%	1.7%	0.2%
Other Income ⓘ	0.15	0.21	0.14	0.16	0.15	0.14	0.17	0.25	0.26	0.30
Interest ⓘ	0.30	0.33	0.33	0.32	0.28	0.25	0.24	0.20	0.19	0.19
Depreciation ⓘ	0.03	0.04	0.04	0.04	0.06	0.05	0.05	0.05	0.05	0.06
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	0.04	0.05	0.07	0.11	0.13	0.26	0.26	0.04	0.05	0.05
Tax ⓘ	0.01	0.02	0.02	0.03	0.03	0.07	0.07	0.02	0.01	0.01
Profit After Tax	0.03	0.03	0.05	0.07	0.09	0.19	0.19	0.02	0.04	0.04
PAT Margin (%)	1.2%	1.3%	1.9%	2.5%	3.1%	5.6%	6.1%	0.9%	1.5%	1.5%
Adjusted EPS (₹)	0.1	0.1	0.1	0.2	0.2	0.5	0.5	0.1	0.1	0.1
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Equity and Liabilities
Shareholders Fund	2.60	2.64	4.80	4.88	4.97	5.15	5.35	5.37	5.41	5.45
Share Capital ⓘ	2.33	2.33	4.06	4.06	4.06	4.06	4.06	4.06	4.06	4.06
Reserves ⓘ	0.28	0.31	0.74	0.81	0.91	1.09	1.29	1.31	1.35	1.39
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	2.07	2.14	2.19	2.14	2.05	1.87	1.45	1.56	1.81	1.66
Long Term Debt	1.49	1.53	1.32	1.10	0.87	0.66	0.59	0.67	0.89	0.63
Short Term Debt	0.58	0.61	0.87	1.04	1.18	1.21	0.86	0.88	0.92	1.03
Trade Payables	0.38	0.43	0.30	0.53	1.05	0.55	0.56	0.44	0.53	0.58
Others Liabilities ⓘ	0.07	0.17	0.03	0.06	0.16	0.18	0.21	0.29	0.25	0.29
Total Liabilities ⓘ	5.13	5.38	7.33	7.61	8.23	7.76	7.57	7.66	8	7.98
Fixed Assets
Gross Block	0.96	0.97	0.98	0.99	1.26	1.29	1.30	1.32	1.33	1.35
Accumulated Depreciation	0.30	0.32	0.36	0.38	0.44	0.49	0.54	0.60	0.65	0.71
Net Fixed Assetsⓘ	0.65	0.65	0.62	0.62	0.82	0.80	0.76	0.72	0.68	0.64
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investmentsⓘ	0.05	0.05	0.50	0	0	0.09	0.09	0.09	0.09	0.09
Inventories	1.13	1.05	1.14	1.12	1.14	1.15	1.04	1.13	1.15	1.18
Trade Receivables	0.69	0.73	0.94	1.25	1.58	1.23	1.07	0.82	0.89	0.89
Cash Equivalents	0.17	0.20	0.22	0.55	0.29	0.24	0.01	0.01	0.02	0.03
Others Assetsⓘ	2.43	2.69	3.90	4.06	4.39	4.25	4.60	4.88	5.17	5.16
Total Assets ⓘ	5.13	5.38	7.33	7.61	8.23	7.76	7.57	7.66	8	7.98

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Cash Flow From Operating Activity ⓘ	-0.21	0.27	-1.05	0.05	0.24	0.11	-0.31	-0.18	-0.21	-0.04
PBT ⓘ	0.04	0.05	0.07	0.11	0.13	0.26	0.26	0.04	0.05	0.05
Adjustment ⓘ	0.03	0.04	0.04	0.19	0.18	0.15	0.11	-0.02	-0.01	-0.06
Changes in Working Capital ⓘ	-0.28	0.19	-1.15	-0.21	-0.03	-0.23	-0.61	-0.18	-0.23	-0.02
Tax Paid ⓘ	-0.01	-0.01	-0.01	-0.04	-0.04	-0.06	-0.06	-0.01	-0.01	-0.02
Cash Flow From Investing Activity ⓘ	-0.23	-0.18	-0.83	0.62	-0.14	0.28	0.37	0.28	0.19	0.49
Capex	-0.02	-0.04	-0.01	0.46	-0.26	-0.03	-0.01	-0.02	-0.01	-0.01
Net Investments	-0.05	0	0	0	0	-0.09	0.21	0.04	-0.05	0.21
Others ⓘ	-0.16	-0.14	-0.82	0.16	0.13	0.40	0.16	0.25	0.26	0.30
Cash Flow From Financing Activityⓘ	0.43	-0.06	1.90	-0.33	-0.36	-0.45	-0.29	-0.10	0.03	-0.44
Net Proceeds from Shares ⓘ	0	0	2.11	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0.01	0	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	-0.31	-0.27	-0.24	-0.22	-0.18	-0.19	-0.19
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0.43	-0.06	-0.23	-0.03	-0.09	-0.21	-0.07	0.08	0.22	-0.26
Net Cash Flow ⓘ	-0.01	0.03	0.02	0.33	-0.26	-0.05	-0.22	0	0.01	0.01

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Ratios
ROE (%)	1.16	1.28	1.36	1.57	1.91	3.7	3.59	0.38	0.7	0.72
ROCE (%)	7.68	8.03	6.88	6.15	5.83	7.26	7.18	3.36	3.41	3.38
Asset Turnover Ratio	0.54	0.51	0.43	0.4	0.39	0.42	0.4	0.31	0.32	0.32
PAT to CFO Conversion(x)	-7	9	-21	0.71	2.67	0.58	-1.63	-9	-5.25	-1
Working Capital Days
Receivable Days	92	96	113	133	169	152	136	145	125	126
Inventory Days	147	148	148	137	135	125	130	167	167	165
Payable Days	172	139	240	68	223	314	164	150	137	156

Ganga Pharmaceuticals Ltd Stock News

Ganga Pharmaceuticals Ltd FAQs

What is the share price of Ganga Pharma.?

Company share prices are keep on changing according to the market conditions. The closing price of Ganga Pharma. on 05-Apr-2024 16:01 is ₹23.50.

What is the market cap of Ganga Pharma.?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 05-Apr-2024 16:01 the market cap of Ganga Pharma. stood at ₹11.37.